UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
July 26, 2018
Accession Number:
0001193125-18-222538
Submission Type:
POS AM
CIK:
0001316175
Company Name:
Anthera Pharmaceuticals Inc
File Number:
333-210166